Commentary: Balancing Upfront Surgery and Neoadjuvant Therapy in Clinically Node-Negative T2–3 Esophageal Squamous Cell Carcinoma
Jae Hyun Jeon · Korean Society for Thoracic & Cardiovascular Surgery · 2026
Acceso al recurso
Entrá al contenido desde la opción principal o elegí otra fuente disponible.
Acceso abierto disponible
Cómo citar
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
Jeon, J. H. (2026). Commentary: Balancing Upfront Surgery and Neoadjuvant Therapy in Clinically Node-Negative T2–3 Esophageal Squamous Cell Carcinoma. https://doi.org/10.5090/jcs.26.073
MLA
Jeon, Jae Hyun. "Commentary: Balancing Upfront Surgery and Neoadjuvant Therapy in Clinically Node-Negative T2–3 Esophageal Squamous Cell Carcinoma." 2026. https://doi.org/10.5090/jcs.26.073.
Chicago
Jeon, Jae Hyun. 2026. "Commentary: Balancing Upfront Surgery and Neoadjuvant Therapy in Clinically Node-Negative T2–3 Esophageal Squamous Cell Carcinoma.". https://doi.org/10.5090/jcs.26.073.
Harvard
Jeon, J. H. 2026, Commentary: Balancing Upfront Surgery and Neoadjuvant Therapy in Clinically Node-Negative T2–3 Esophageal Squamous Cell Carcinoma, Korean Society for Thoracic & Cardiovascular Surgery, available at: https://doi.org/10.5090/jcs.26.073 [Accessed 29 Jun. 2026].
Detalles del recurso
Información bibliográfica útil para confirmar que se trata del material correcto.
- Título
- Commentary: Balancing Upfront Surgery and Neoadjuvant Therapy in Clinically Node-Negative T2–3 Esophageal Squamous Cell Carcinoma
- Autor / colaboradores
- Jae Hyun Jeon
- Editorial
- Korean Society for Thoracic & Cardiovascular Surgery
- Año de publicación
- 2026
- ISSN
- 2765-1606
- ISSN
- 2765-1606
- Idioma
- eng